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Abstract  Improving  access  to  diagnosis  constitutes  a  key  step  in  the  control  of  the  Human
immunodeficiency  virus  (HIV)/AIDS  epidemic.  Rapid  testing  is  increasingly  gaining  interest  as  a
powerful  diagnostic  tool  to  achieve  this  goal.  The  purpose  of  this  study  was  to  implement  the
rapid HIV  test  (RHT)  in  a  clinical  setting  in  order  to  evaluate  its  effectiveness  in  increasing  HIV
diagnosis  and  patient  linkage  to  the  healthcare  system.
The  RHT  was  offered  to  all  patients  attending  a  sexually-transmitted  disease  clinic  in  the  City
of Buenos  Aires  between  March  and  December  2015.  A  total  of  593  RHT  were  performed.  The
implementation  of  the  RHT  yielded  an  increase  in  frequency  of  diagnosis  from  6.9%  to  31.4%
(p <  0.001).  The  first  steps  of  the  care  cascade  showed  high  retention  rates  around  90%.  RHT
yielded an  HIV  prevalence  of  6.3%  (95%  CI:  4.2--8.5)  in  this  population.  HIV  prevalence  tended  to
be higher  in  individuals  with  no  previous  HIV  testing  (p  =  0.09).  Linkage  to  the  healthcare  system
was associated  with  a  higher  probability  of  having  been  tested  for  HIV  (p  =  0.008).  The  incorpo-
ration of  the  RHT  resulted  in  a  high  retention  of  patients  and  an  increase  in  both  frequency  of
diagnosis  and  results  reception  when  compared  to  the  classic  methodology.
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Incorporación  del  test  rápido  del  HIV  en  una  clínica  de  enfermedades  de  transmisión
sexual  en  Buenos  Aires:  aumento  dramático  en  la  frecuencia  de  diagnóstico  del  HIV
Resumen  El  mejoramiento  del  acceso  al  diagnóstico  constituye  un  punto  clave  en  el  control
de la  epidemia  del  virus  de  la  inmunodeficiencia  humana  (Human  immunodeficiency  virus:
HIV)/sida.  El  testeo  rápido  se  ha  convertido  en  una  poderosa  herramienta  diagnóstica  de  interés
para alcanzar  este  objetivo.  El  propósito  de  este  estudio  fue  la  implementación  del  test  rápido
del HIV  (TRH)  en  un  contexto  clínico  con  el  fin  de  evaluar  su  efectividad  para  incrementar  la
tasa de  diagnóstico  de  HIV  y  la  vinculación  de  los  pacientes  al  sistema  de  salud.
Se ofreció  el  TRH  a  todos  los  pacientes  que  acudieron  a  una  clínica  de  enfermedades  de
transmisión  sexual  en  la  Ciudad  Autónoma  de  Buenos  Aires  entre  marzo  y  diciembre  del  2015.
Se realizaron  un  total  de  593  TRH.  La  implementación  del  TRH  resultó  en  un  aumento  en  la
frecuencia  de  diagnóstico  del  6,9  al  31,4%  (p  <  0,001).  Los  primeros  pasos  en  la  cascada  de
cuidados mostraron  altas  tasas  de  retención  alrededor  del  90%.  La  prevalencia  del  HIV  según  TRH
en la  población  de  estudio  fue  del  6,3%  (IC  95%:  4,2-8,5),  tendiendo  a  ser  mayor  en  individuos
sin testeo  previo  de  HIV  (p  =  0,09).  La  vinculación  al  sistema  de  salud  se  asoció  a  una  mayor
probabilidad  de  haber  sido  testeado  previamente  para  HIV  (p  =  0,008).  La  incorporación  del  TRH
resultó en  una  mayor  retención  de  los  pacientes,  así  como  en  un  aumento  tanto  en  la  frecuencia
de diagnóstico  como  en  la  de  retiro  de  resultados,  en  comparación  con  la  metodología  clásica.
© 2020  Asociación  Argentina  de  Microbioloǵıa.  Publicado  por  Elsevier  España,  S.L.U.  Este  es  un




























































qualitative  detection  of  antibodies  against  HIV-1/2  antigens.
The  test  was  carried  out  according  to  the  manufac-ntroduction
iven  the  worldwide  commitment  to  end  the  epidemic  by
030,  UNAIDS  (The  Joint  United  Nations  Programme  on  HIV
nd  AIDS)  has  set  a  series  of  objectives  for  the  year  2020:
hat  90%  of  all  people  living  with  HIV  become  aware  of
heir  infection,  that  90%  of  those  aware  of  their  infection
ain  access  to  treatment  and  that  90%  of  those  on  treat-
ent  suppress  their  viral  load  one  year  after  the  infection17.
his  highlights  the  importance  of  improved  access  to  diag-
osis  as  the  first  step  in  the  control  of  the  HIV/AIDS
pidemic.  However,  there  still  remains  much  to  be  done
n  this  area,  considering  the  high  frequency  of  late  diag-
oses  worldwide8,13.  In  this  context,  rapid  HIV  tests  (RHT)
re  essential  tools  to  achieve  the  90--90--90  target  due  to
heir  proved  efficacy  in  facilitating  access  to  diagnosis10.
In  Argentina,  HIV  prevalence  has  been  estimated  to  be
.4%  among  young  people  and  adults.  The  epidemic  is  mostly
oncentrated  in  men  who  have  sex  with  men  (MSM)  and
ransgender  women,  with  HIV  prevalence  rates  of  12--15%
nd  34%,  respectively.  Moreover,  it  has  been  reported  that
pproximately  37.5%  of  men  and  30%  of  women  receive  a
ate  HIV  diagnosis2.  Even  when  international  studies  clearly
ssociated  RHT  introduction  with  increased  HIV  testing  in
everal  settings,  only  one  research  study  on  the  implemen-
ation  of  the  RHT  has  been  performed  in  Argentina5.  Given
he  need  for  local  data  on  the  implications  of  the  incorpo-
ation  of  the  RHT  into  the  diagnostic  algorithms,  our  goal
as  to  test  the  effectiveness  of  a  structural  intervention:
he  incorporation  of  the  RHT  followed  by  immediate  coun-
eling,  diagnosis  confirmation  and  entry  to  care  in  a  walk-in
exually-transmitted  disease  (STD)  clinic  located  in  a  Uni-
ersity  Hospital  (Programa  de  Enfermedades  de  TransmisiónPlease  cite  this  article  in  press  as:  Morando  N,  et  al.  Incorp
disease  clinic  in  Buenos  Aires:  Dramatic  increase  in  the  fr
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exual  (PETS),  Hospital  de  Clínicas  ‘‘José  de  San  Martin’’




nrollment  of  participants
 diagnostic  algorithm  was  designed  in  line  with  those  rec-
mmended  by  the  national  health  ministry1,  in  particular
he  one-rapid-test  screening  algorithm.  Between  March  and
ecember  2015  the  RHT  was  offered  to  all  patients  attending
he  STD  clinic  who  met  eligibility  criteria.  Eligible  patients
ere  men  and  women  who  were  18  years  old  or  older  who
ttended  the  clinic  regardless  of  the  reason  for  consultation.
uring  the  process  of  registration  each  patient  was  told  that
he  test  would  be  carried  out  from  a  finger  prick  blood  sam-
le  and  that  the  result  would  be  informed  to  them  directly
y  the  physician  during  the  consultation.  Those  who  mani-
ested  interest  were  given  an  informed  consent  for  them  to
ead  and  sign,  as  well  as  a  survey  to  complete  in  order  to
ollect  socio-demographical  data  and  information  related  to
exual  behavior,  linkage  to  the  healthcare  system  and  pre-
ious  HIV  testing.  Upon  reading,  completing  and  signing  this
ocumentation,  they  were  enrolled  in  the  study  and  indi-
idually  led  to  a  room  which  was  especially  conditioned  for
arrying  out  the  test.
apid  HIV  test  and  delivery  of  results
he  RHT  was  performed  by  collecting  a  blood  sample
hrough  a  finger  prick,  using  the  commercial  kit  DetermineTM
IV-1/2  (Alere),  an  immunochromatographic  test  for  theoration  of  the  rapid  HIV  test  in  a  sexually-transmitted
equency  of  HIV  diagnosis.  Rev  Argent  Microbiol.  2020.
urer’s  instructions  and  the  results  were  available  within
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and/or  researcher  in  charge  and  delivered  to  the  physician
for  him  to  read  and  to  show  to  the  patient.  In  the  event
of  a  non-reactive  RHT,  the  physician  gave  the  patient  the
necessary  recommendations  based  on  reported  risk  factors.
In  case  of  reactive  RHT,  on  the  other  hand,  the  patient
was  informed  about  the  need  for  further  confirmatory  stud-
ies  and  referred  to  the  INBIRS  diagnostic  laboratory,  which
is  located  in  the  nearby  School  of  Medicine  (Facultad  de
Medicina,  Universidad  de  Buenos  Aires), approximately  100
meters  away  from  the  University  Hospital.
HIV  confirmatory  studies  and  delivery  of  results
A  15-ml  peripheral  blood  sample  was  taken  from  those
individuals  with  reactive  RHT  who  attended  the  INBIRS
laboratory  for  confirmatory  studies,  which  included  ELISA
(Genscreen  Ultra  HIV  Ag-AbBio-rad),  plasma  viral  load
(Abbott  Real  Time  HIV-1  RNA  Version  3.0)  and  CD4  +  T  cell
count  (flow  citometry).  The  results  were  sent  to  the  clinic
and  handed  over  to  the  patient  by  the  same  physician  during
a  second  visit.  Patients  with  confirmed  HIV  diagnosis  were
referred  to  the  Infectious  Diseases  Unit  of  the  University
Hospital  (Departamento  de  Infectología,  Hospital  de  Clíni-
cas  ‘‘José  de  San  Martín’’,  Universidad  de  Buenos  Aires) in
order  to  be  assisted.  Patient  follow-up  was  performed  by
regular  reviewing  of  clinical  records  for  a  period  of  one  year
following  the  study  period.
Statistical  analysis
Fisher’s  exact  test  and  Mann--Whitney  U  test  were  used  to
compare  differences  in  categorical  and  numerical  variables,
respectively.  All  statistical  analyses,  including  calculation
of  interquartile  ranges  (IQR)  and  95%  confidence  intervals
(95%  CI)  were  carried  out  using  IBM  SPSS  Statistics  Base  22.0
(IBM  Corp.  Released  2013.  IBM  SPSS  Statistics  for  Windows,
Version  22.0.  Armonk,  NY:  IBM  Corp.).
Ethical  aspect
All  the  procedures  were  in  line  with  the  Declaration  of
Helsinki  (Seoul  2008),  the  National  Personal  Information
Protection  Law  (Law  25326)  and  followed  the  recommen-
dations  provided  by  national  regulations  for  research.  The
protocol  of  the  study,  as  well  as  the  documentation  used
(namely,  informed  consent  and  survey)  were  evaluated  and
approved  by  the  University  Hospital  Institutional  Review
Board  (IRB)  (Comité  de  Ética,  Hospital  de  Clínicas  ‘‘José
de  San  Martín’’,  Universidad  de  Buenos  Aires). Informed
consent  was  obtained  from  all  study  participants.
Results
Socio-demographic  characteristics  of  the  study
population
Between  March  and  December  2015,  a  total  of  593  RHTPlease  cite  this  article  in  press  as:  Morando  N,  et  al.  Incorp
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were  performed  on  547  patients  (39  patients  were  tested
twice,  six  patients  three  times  and  one  patient  four  times;
there  were  no  duplicate  cases  among  reactive  RHT).  Unless







he  non-duplicate  cases.  Considering  gender  at  birth,  76.8%
420/547)  of  participants  were  men  and  23.2%  (127/547)
ere  women.  Regarding  self-identified  gender,  most  individ-
als  identified  themselves  as  male  (75.6%,  403/533),  others
s  female  (22.5%,  120/533)  and  a  small  minority  as  trans-
ender  (1.3%,  7/533).  Table  1  shows  all  socio-demographic
haracteristics,  stratified  by  self-identified  gender.  Briefly,
he  patients’  median  age  was  29  years  (IQR:  24--38),  with
elf-identified  males  being  significantly  older  than  females
males:  29  years  old,  IQR:  25--39;  females:  27  years  old,
QR:  22--33.75;  Mann--Whitney  test,  p  =  0.001).  Transgender
ndividuals  showed  a  higher  median  age  (32  years  old,  IQR:
3--35).  However,  no  statistically  significant  difference  could
e  inferred  either  with  males  (p  =  0.84)  or  females  (p  =  0.42).
ost  patients  lived  in  Buenos  Aires,  the  capital  city  (72.6%,
23/445),  or  in  the  Buenos  Aires  Province  (26.3%,  117/445).
ost  individuals  (74.5%,  404/542)  reported  having  com-
leted  high  school  education  level.  Regarding  work  status,
8.6%  (201/521)  had  a  steady  job,  i.e.  with  a  contract,  29.9%
156/521)  had  an  unsteady  job,  i.e.  without  a  contract,
hile  the  remaining  individuals  who  reported  not  having  a
ob  were  unemployed,  retired  or  students.
revious  linkage  to  care  and  HIV  testing
egarding  linkage  to  the  healthcare  system,  73.6%  (393/534)
f  patients  reported  receiving  some  kind  of  medical  ser-
ice  during  the  previous  year.  Most  patients  (67.5%,  363/538)
ad  been  tested  for  HIV  previously,  and  94.5%  (294/311)  of
hem  reported  receiving  their  results.  Probability  of  having
een  tested  for  HIV  in  the  past  was  higher  in  patients  who
eported  receiving  any  kind  of  medical  service  during  the
revious  year  as  opposed  to  none  (71.0%  (277/390)  vs.  58.6.%
82/140),  p  = 0.008)  and  men  with  reported  male  partners
s  opposed  to  female  partners  (86.0%  (141/164)  vs.  60.7%
125/206),  p  <  0.001).  Inconsistent  condom  use  was  more
requent  in  patients  with  no  previous  HIV  test  when  com-
ared  to  those  previously  tested  (82.9%  (136/164)  vs.  71.8%
249/347),  p  =  0.006).
exual  practices  and  condom  use
egarding  sexual  practices,  51.3%  (210/409)  of  men
eported  having  sexual  relationships  only  with  women  in
he  six  months  prior  to  the  study,  while  40.3%  (165/409)
eported  having  male  sexual  partners.  The  remaining  men
ad  either  both  male  and  female  (3.9%,  16/409),  female
nd  trans  (0.7%,  3/409),  only  trans  (0.5%,  2/409)  or  no  sex-
al  partners  (3.2%,  13/409).  In  the  case  of  women,  the  vast
ajority  (95.2%,  120/126)  reported  having  only  male  sexual
artners,  while  only  2.4%  (3/126)  claimed  to  have  no  sexual
artners  during  the  previous  six  months.  Only  a  handful  of
omen  reported  both  male  and  female  (1.6%,  2/126)  or  only
emale  (0.8%,  1/126)  sexual  partners.
Concerning  condom  use,  only  25.2%  (130/516)  of  par-
icipants  reported  consistent  condom  use  during  sexual
elationships,  while  9.7%  (50/516)  claimed  never  to  useoration  of  the  rapid  HIV  test  in  a  sexually-transmitted
equency  of  HIV  diagnosis.  Rev  Argent  Microbiol.  2020.
 condom  and  the  rest  reported  inconsistent  condom  use
65.1%,  336/516).  Consistent  condom  use  was  more  fre-
uent  among  men  than  women  (29.3%  (116/396)  vs.  11.7%
14/120),  p  =  0.0001).  Patients  without  a previous  HIV  test
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Table  1  Socio-demographic  characteristics  of  the  547  participants  included  in  the  study  between  March  and  December  2015
in the  STD  clinic  in  Buenos  Aires,  Argentina.
Total  Male  Female  Trans
Median  age  (IQR)**,a 29  (24--38)  29  (25--39)  27  (22--33.75)  32  (23--35)
Residence
City of  Buenos  Aires 72.6%  (323/445) 72.6%  (239/329) 70.3%  (71/101)  100%  (4/4)
Other 27.4%  (122/445) 27.4%  (90/329) 29.7%  (30/101) --
Education  level
Complete  high  school 74.5%  (404/542) 75.5%  (302/400) 75.0%  (90/120) 42.9%  (3/7)
Incomplete high  school  25.5%  (138/542)  24.5%  (98/400)  25.0%  (30/120)  57.1%  (4/7)
Employment status
Steady  job  with  contract  38.6%  (201/521)  39.3%  (153/389)  35.7%  (41/115)  20.0%  (1/5)
Unsteady job  without  contract  29.9%  (156/521)  30.8%  (120/389)  25.2%  (29/115)  60.0%  (3/5)
Other 31.5%  (164/521)  29.8%  (116/389)  39.1%  (45/115)  20.0%  (1/5)
Student
Yes 13.6%  (71/521)  13.9%  (54/388)  12.9%  (15/116)  20.0%  (1/5)
No 86.4%  (450/521)  86.1%  (334/388)  87.1%  (101/116)  80.0%  (4/5)
Last visit  to  a  doctor
<1 year  73.6%  (393/534)  74.1%  (295/398)  73.7%  (87/118)  71.4%  (5/7)
>1 year  21.7%  (116/534)  21.4%  (85/398)  22.0%  (26/118)  14.3%  (1/7)
Does not  know/remember  4.7%  (25/534)  4.5%  (18/398)  4.2%  (5/118)  14.3%  (1/7)
Previous HIV  test*
Yes  67.5%  (363/538)  70.2%  (280/399)  57.1%  (68/119)  85.7%  (6/7)
No 32.5%  (175/538)  29.8%  (119/399)  42.9%  (51/119)  14.3%  (1/7)
Sex partners  in  the  last  six  months
Male***  56.5%  (293/519) 46.9%  (179/382)  90.8%  (108/119)  85.7%  (6/7)
Female*** 43.7%  (227/519) 57.1%  (218/382) 7.6%  (9/119)  --
Trans 1.0%  (5/519) 1.0%  (4/382)  --  14.3%  (1/7)
None 3.1%  (16/519) 3.4%  (13/382) 2.5%  (3/119)  --
Condom use**
Regular  25.2%  (130/516)  28.7%  (110/383)  14.5%  (17/117)  50.0%  (3/6)
Irregular 74.8%  (386/516)  71.3%  (273/383)  85.5%  (100/117)  50.0%  (3/6)

































(*p < 0.05, **p < 0.01, ***p  < 0.001). Denominators vary due to the f
questions. IQR: interquartile range.
lso  showed  a  higher  frequency  of  inconsistent  condom  use
82.9%  (136/164)  vs.  71.8%  (249/347),  p  =  0.006)  when  com-
ared  with  those  previously  tested.
IV  prevalence  and  associated  risk  factors
ccording  to  RHT,  HIV  prevalence  was  6.3%  (34/538,  95%
I:  4.2--8.5),  with  a  significant  higher  prevalence  in  men
han  in  women  (7.5%  (31/412)  vs.  2.4%  (3/126),  p  =  0.04).
atients  who  had  not  been  tested  for  HIV  showed  a  ten-
ency  toward  a  higher  HIV  prevalence  than  those  who  had
een  tested  once  (9.1%  (16/175)  vs.  5.1%  (18/354),  p  =  0.09).
hen  accounting  for  sexual  partner  type,  a  significant  higher
IV  prevalence  was  found  among  men  who  had  exclusively
ale  partners  as  opposed  to  exclusively  female  partnersPlease  cite  this  article  in  press  as:  Morando  N,  et  al.  Incorp
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15.0%  (24/160)  vs.  1.9%  (4/207),  p  <  0.001).  No  significant
ifferences  in  HIV  prevalence  were  observed  between  parti-
ipants  who  reported  consistent  or  inconsistent  condom  use





hat not all participants answered all demographic and risk factor
atient  referral  and  first  steps  in  the  cascade  of
are
ll  patients  with  a  reactive  RHT  (n  =  34)  were  referred  to
he  laboratory  for  confirmatory  studies;  94.1%  (32/34)  went
o  the  laboratory,  and  87.5%  (28/32)  came  back  in  order  to
eceive  their  results.  The  infection  was  confirmed  in  93.8%
30/32)  of  patients,  yielding  two  false  reactive  RHT  results.
mong  HIV  positive  patients  (n  =  30),  the  median  CD4  +  T
ell  count  was  441  cells/l (p25--p75,  288--608)  and  the
edian  HIV  viral  load  was  28  764  RNA  copies/ml  (p25--p75,
446--59  177).  The  two  cases  classified  as  false  positives
ere  confirmed  as  HIV  negative  according  to  plasma  viral
oad,  fourth-generation  ELISA  and  immunological  parame-
ers.  Of  the  30  confirmed  HIV-positive  individuals,  we  wereoration  of  the  rapid  HIV  test  in  a  sexually-transmitted
equency  of  HIV  diagnosis.  Rev  Argent  Microbiol.  2020.
ble  to  do  follow-up  13  of  them,  i.e.  43.3%.  Among  these,
9.2%  (9/13)  repeated  the  laboratory  tests,  namely  CD4  +  T
ell  count  and  plasma  HIV  viral  load,  and  76.9%  (10/13)
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55.6%  (5/9)  managed  to  suppress  their  viral  load  during  the
course  of  the  follow-up  period.  Regardless  of  the  presence
or  absence  of  viral  suppression,  all  patients,  except  for  one
patient,  had  a  lower  viral  load  by  the  time  of  the  final  exam-
ination,  which  took  place  4--14  months  after  the  base-line
test.
Influence  of  rapid  testing  on  frequency  of  HIV
diagnosis
To  evaluate  the  impact  of  the  incorporation  of  the  RHT
on  the  frequency  of  patients  who  agreed  to  be  tested
for  HIV,  we  compared  the  frequency  of  the  previous  year
performed  by  the  conventional  methodology  (referral  to
laboratory,  peripheral  blood  collection,  laboratory  analyses
(ELISA,  Western  Blot)  and  delivery  of  results  within  15  days)
with  the  frequency  of  patients  tested  by  RHT  in  our  study.  In
the  year  prior  to  the  study,  6.9%  (210/3060)  of  the  patients
who  attended  the  clinic  agreed  to  be  tested,  while  this  fre-
quency  rose  to  31.4%  (593/1887)  during  the  study  period
(p<  0.001)(this  includes  duplicate  cases).  We  also  observed
a  slight  increment  in  the  reception  of  confirmatory  results
from  76.2%  (160/210)  to  87.5%  (28/32)  (p  =  0.6746).
Discussion
This  study  reveals  for  the  first  time  in  Argentina  how  the
incorporation  of  the  RHT  in  the  diagnostic  algorithm  can
cause  a  dramatic  increase  in  the  frequency  of  HIV  diagnosis
(almost  five-fold)  as  observed  in  the  comparison  between
the  results  of  the  present  study  and  the  period  prior  to
the  study,  i.e.  with  and  without  the  use  of  the  RHT.  This
is  consistent  with  previous  studies  performed  in  other  coun-
tries  comparing  the  uptake  of  HIV/AIDS  services  using  RHT
and  conventional  testing,  where  the  implementation  of  RHT
was  associated  with  a  three-fold  increase  in  the  frequency
of  diagnosis14,18.  Even  when  the  use  of  RHT  significantly
increases  the  rate  of  HIV  diagnosis,  the  frequency  (∼= 30%)
is  still  lower  than  that  reported  previously  in  other  studies
where  acceptability  of  rapid  tests  ranged  from  45%  to  95%.
However,  uptake  of  RHT  depended  on  the  venue  where  test-
ing  was  offered  as  well  as  the  risk  group  to  which  clients
belonged,  for  example,  acceptability  has  been  reported  to
be  higher  in  pregnant  women  and  lower  among  clients  of  sex
workers  (45%),  black  university  students  tested  on  campus
(50%)  and  African  and  Caribbean  clients  in  family  practice
(45%)3,12,15.  Low  RHT  acceptability  among  some  populations
may  be  related  to  the  fact  that  they  did  not  expect  to  be
offered  a  test  or  do  not  perceive  themselves  to  be  at  risk
for  HIV.  Due  to  the  fact  that  at  the  time  of  the  study  it  was
not  very  common  to  find  RHT  offer  in  medical  services;  the
poor  acceptability  can  be  related  to  the  issues  mentioned.
This  rapid  HIV  testing  approach  not  only  effectively
increased  the  number  of  individuals  tested  but  also  reached
individuals  at  risk  for  HIV,  as  can  be  seen  by  the  high  HIV
prevalence  detected.  This  was  found  to  be  almost  6%,  which
is  considerably  higher  than  that  of  the  general  populationPlease  cite  this  article  in  press  as:  Morando  N,  et  al.  Incorp
disease  clinic  in  Buenos  Aires:  Dramatic  increase  in  the  fr
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(below  1%)2.  The  reason  for  this  might  lie  in  the  fact  that  the
individuals  included  in  this  study  are  already  seeking  medical
attention  for  STD-related  --  real  or  suspected  --  prob-







revalence  of  STDs  in  general,  including  HIV.  We  also
ound  that  HIV  positive  individuals  reached  in  this  study
ave  a  median  CD4  +  T  cell  count  below  500  cells/l,
hich  suggests  late  HIV  diagnosis.  This  result  is  of  great
mportance  considering  the  evidence  that  indicate  that
mmediate  antiretroviral  therapy,  with  CD4  +  T  cells  count
ver  500  cells/ml,  can  reduce  disease  progression,  improv-
ng  the  likelihood  of  immunologic  recovery  while  also
ncreasing  the  percentage  of  individuals  who  achieve  viral
uppression7,16.
Our  findings  underscore  the  importance  of  increasing  the
ate  of  HIV  diagnosis  by  improving  patient  linkage  to  the
ealthcare  system.  One  in  four  patients  had  had  no  contact
ith  any  health  service  for  over  a  year  and  HIV  testing
as  significantly  less  frequent  among  them,  which  is  con-
istent  with  previous  studies4,6,11.  This  association  between
inkage  to  healthcare  system  and  HIV  testing  highlights  the
mportance  of  interventions  to  bring  individuals  to  clin-
cs/hospitals  and  identify  opportunities  for  rapid  HIV  testing
n  these  environments.  The  model  tested  in  this  study  could
e  applied  in  other  clinics  with  similar  characteristics,  as
ong  as  it  does  not  involve  additional  time  for  the  patient
r  moving  to  another  place  to  be  tested.  From  this  find-
ng,  it  would  be  pertinent  to  recommend  including  the  RHT
n  STDs  clinics.  To  achieve  this,  it  would  be  imperative  to
ave  minimal  requirements  like  funding,  room,  and  trained
ersonnel.
It  has  been  previously  reported  that  rapid  testing  reduces
aiting  times  for  the  patient,  favoring  linkage  and  retention
n  care9.  Accordingly,  our  approach  to  the  first  steps  of  the
ascade  of  care  with  RHT  shows  encouraging  outcomes,  with
igh  retention  rates  (around  90%).  However,  our  study  has
ertain  limitations  that  need  to  be  addressed.  Our  exper-
mental  design  only  allowed  us  to  closely  follow  the  first
ew  steps  of  the  care  cascade  --  further  inquiry  is  neces-
ary  to  determine  if  the  beneficial  effect  observed  applies
o  the  entire  chain,  from  testing  to  treatment  and  viral  sup-
ression.  Finally,  a  higher  sample  size  might  have  enabled
s  to  examine  socio-demographic  and  conduct  differences
etween  other,  less  frequent  populations,  such  as  trans,
hich  here  were  only  found  in  very  low  numbers.  New  stud-
es  aimed  at  applying  the  implementation  of  HIV  diagnosis
ia  rapid  testing  would  strongly  benefit  from  these  additions.
onclusions
n  conclusion,  results  obtained  in  this  study  confirm  those
f  previous  interventions  performed  in  other  countries
nd  highlight  the  importance  of  facilitating  patient  access
o  diagnosis  and  retention  within  the  healthcare  system.
he  incorporation  of  the  RHT  resulted  in  a  high  reten-
ion  of  patients  and  an  increase  in  both  the  frequency  of
iagnosis  and  results  withdrawal  when  compared  to  the
onventional  methodology.  Other  notable  achievements  of
he  study  in  this  respect  include  the  successful  incorpo-
ation  of  RHT  in  a walk-in  clinic,  with  high  acceptance
nd  efficacy.  Last  but  not  least,  the  testing  methodologyoration  of  the  rapid  HIV  test  in  a  sexually-transmitted
equency  of  HIV  diagnosis.  Rev  Argent  Microbiol.  2020.
mployed,  based  on  the  open  offer  of  the  RHT  without
isrupting  the  normal  circuit  of  the  clinic,  is  potentially
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